Stock price
-
The “Black Monday” for CNS drug-developing companies. Is the placebo “going wild and uncontrollable”?
To explore more efficient and stable clinical trial protocols, these “failures” are inevitably part of the cost
-
BioTech Revelation: What to Do When the Pipeline Fails?
For more articles, please follow DrugTimes. Many thanks!
-
AbbVie’s stock price plummets!
Drug discovery and development is not easy at all. We pay high respect to these heroes
-
One good drug can change fate! Summit’s stock price soars by 119%, with its market value increasing more than a hundredfold
For upcoming reports, please follow DrugTimes
-
As the 10th anniversary of approval approaches，Keytruda adds ‘potential’ performance to Merck
DrugTimes will follow up on this subject. Please stay tuned
